Grow your brand, now and through patent expiry
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREEvery year, brand teams face the same question: how can we improve our brand’s performance? Except in those cases where new clinical data are available to either demonstrate efficacy or support a new indication, they must do so with the existing label.
Brand teams usually have a good understanding of what can be improved with brands that have been on the market and have a performance history. However, they are usually less certain as to how to improve recently launched brands that are under-performing.
In either case, brand teams have an understandably difficult time determining which performance levers will yield the largest impact to improve the brand’s overall performance. Which investments will have the greatest impact – and at what cost? In the absence of anything concrete to go on, they make this decision, at best, as an educated guess and, at worst, as a shot in the dark.
It is possible, however, to rely on an evidence-based framework to decide where to focus to improve brand performance effectively. Here, we describe a novel, new framework (so unique, in fact, that a patent is pending on it) that reduces the complexity of brand decisions by quantifying the impact that can be expected from various tactics.
Grow your brand, now and through patent expiry
Launch with confidence and excellence the first time.
Learn how unparalleled data, domain expertise, and technologies enable AI-powered solutions that are purpose-built for healthcare.